Chloroquine and sulfadoxine–pyrimethamine resistance in Sub-Saharan Africa—A review

AT Roux, L Maharaj, O Oyegoke, OP Akoniyon… - Frontiers in …, 2021 - frontiersin.org
Malaria is a great concern for global health and accounts for a large amount of morbidity and
mortality, particularly in Africa, with sub-Saharan Africa carrying the greatest burden of the …

The host targeting effect of chloroquine in malaria

C Coban - Current opinion in immunology, 2020 - Elsevier
Highlights•Chloroquine/hydroxychloroquine is an old anti-malarial drug belongs to 4-
aminoquinolines.•Chloroquine has additional anti-virus, anti-bacteria, anti-protozoan, anti …

Antimalarial quinoline drugs inhibit β-hematin and increase free hemin catalyzing peroxidative reactions and inhibition of cysteine proteases

T Herraiz, H Guillén, D González-Peña, VJ Arán - Scientific reports, 2019 - nature.com
Malaria caused by Plasmodium affects millions people worldwide. Plasmodium consumes
hemoglobin during its intraerythrocytic stage leaving toxic heme. Parasite detoxifies free …

Repurposing chloroquine against multiple diseases with special attention to SARS-CoV-2 and associated toxicity

S Kamat, M Kumari - Frontiers in Pharmacology, 2021 - frontiersin.org
Chloroquine and its derivatives have been used since ages to treat malaria and have also
been approved by the FDA to treat autoimmune diseases. The drug employs pH-dependent …

[HTML][HTML] Exploring the Antimalarial Efficacy of Globimetula oreophila Leaf Fractions in Plasmodium berghei-infected Mice: In Vivo Approach

D Garba, BH Ali, B Bawa, A Sanusi, YM Sani… - Sciences of …, 2024 - etflin.com
The development of parasite resistance to first-line antimalarial medicines, especially the
Artemisinin-based combination therapies (ACTs), has made the research and development …

PfMDR1 Transport Rates Assessed in Intact Isolated Plasmodium falciparum Digestive Vacuoles Reflect Functional Drug Resistance Relationship with pfmdr1 …

N Simon, C Voigtländer, B Kappes, P Rohrbach… - Pharmaceuticals, 2022 - mdpi.com
Drug resistance often emerges from mutations in solute transporters. Single amino acid
exchanges may alter functionality of transporters with 'de novo'ability to transport drugs away …

Antimalarial drugs

BJ Sawyer, MIH Khan, HV Le - Medicinal Chemistry of Chemotherapeutic …, 2023 - Elsevier
Malaria is a mosquito-borne infectious disease that remains one of the world's most frequent
causes of morbidity and mortality. According to the World Malaria Report 2021, published by …

Uptake of a fluorescently tagged chloroquine analogue is reduced in CQ-resistant compared to CQ-sensitive Plasmodium falciparum parasites

SJ Reiling, P Rohrbach - Malaria Journal, 2019 - Springer
Background Chloroquine (CQ) was the drug of choice for decades in the treatment of
falciparum malaria until resistance emerged. CQ is suggested to accumulate in the …

Identification of an inhibitory pocket in falcilysin provides a new avenue for malaria drug development

G Wirjanata, J Lin, JM Dziekan, A El Sahili, Z Chung… - Cell Chemical …, 2024 - cell.com
Identification of new druggable protein targets remains the key challenge in the current
antimalarial development efforts. Here we used mass-spectrometry-based cellular thermal …

Recombinant C-Terminal Domains from Scorpine-like Peptides Inhibit the Plasmodium berghei Ookinete Development In Vitro

L Vargas-Jaimes, MC Rodriguez… - International Journal of …, 2021 - Springer
Malaria is a parasitic disease, caused by protozoa of the genus Plasmodium, and is
transmitted to humans through the bites of infected Anopheles mosquitoes. More than 200 …